Deferasiroks Pliva 500 mg tablete za oralnu suspenziju
Name | Deferasiroks Pliva 500 mg tablete za oralnu suspenziju |
---|---|
Marketing Authorisation Number | HR-H-536900861 |
Active Substance | deferasiroks |
Composition | svaka tableta za oralnu suspenziju sadrži 500 mg deferasiroksa |
Pharmaceutical Form | tableta za oralnu suspenziju |
Packaging [MA Number for Packaging] | 28 tableta u blisteru, u kutiji [HR-H-536900861-01] 28 tableta u blisteru s jediničnom dozom, u kutiji [HR-H-536900861-02] 30 tableta u blisteru, u kutiji [HR-H-536900861-03] 30 tableta u blisteru s jediničnom dozom, u kutiji [HR-H-536900861-04] 84 tablete u blisteru, u kutiji [HR-H-536900861-05] 84 tableta u blisteru s jediničnom dozom, u kutiji [HR-H-536900861-06] 98 tableta u blisteru, u kutiji [HR-H-536900861-07] 98 tableta u blisteru s jediničnom dozom, u kutiji [HR-H-536900861-08] 294 (3 pakiranja od 98 tableta u blisteru u kutiji) tableta, u kutiji [HR-H-536900861-09] |
Manufacturer | Merckle GmbH, Blaubeuren, Njemačka Pliva Hrvatska d.o.o., Zagreb, Hrvatska |
Marketing Authorisation Holder | Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska |
Marketing Authorisation Date | 07.04.2022 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/21-02/197 |
Registration Number | 381-12-01/154-22-02 |
Prescription | na recept |
Type of prescription | ograničeni recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | V03AC03 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Public Assessment Report | download |
Educational materials for healthcare professionals |
Vodič za zdravstvene radnike, verzija 2 |
Educational materials for patients / caregivers |
Vodič za bolesnike, verzija 2 |